SKP2 and cancer: Notably, SKP2 expression has been correlated with shorter overall survival in patients with HNSCC(50) and is often inversely associated with CDKN1C expression in various cancers.(51,52) In OSCC, positive CDKN1C staining was correlated with higher 5-year survival rates.